Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy
Simple Summary
Abstract
1. Introduction
2. Materials and Methods
2.1. Patient Selection
2.2. Radiologic Assessment
- Gerota’s fascia thickness (mm);
- Distance from tumor to renal sinus (mm);
- Contact surface area (CSA, cm2);
- Tumor depth (mm);
- Tumor radius (mm);
- Nearness to collecting system (mm);
- Renal diameters: anteroposterior, laterolateral, and longitudinal (mm);
- Tumor diameters: anteroposterior, laterolateral, and longitudinal (mm);
- Medullary invasion (yes/no);
- Hilar location (yes/no);
- Tumor margin (linear/irregular);
- Presence of pseudocapsule (yes/no);
- Presence of necrosis (yes/no);
- Tumor nature (solid/cystic);
- Tumor rim location (medial/lateral);
- Location relative to polar lines (upper/mid/lower);
- Longitudinal location (superior/midline/inferior);
- Tumor location (anterior/posterior);
- Exophytic rate (>50%/<50%/endophytic);
- RENAL nephrometry score (4–6/7–9/10–12).
2.3. Baseline, Perioperative and Functional Outcomes
- Negative surgical margins;
- Absence of major complications (Clavien–Dindo ≥ 3);
- eGFR decline < 30% at discharge.
2.4. Statistical Analysis
3. Results
4. Discussion
5. Conclusions
Supplementary Materials
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
Abbreviations
| ocMIPN | Off-clamp minimally invasive partial nephrectomy |
| CSA | Contact surface area |
| MIPN | Minimally invasive partial nephrectomy |
| ICC | Intraclass correlation coefficient |
| BMI | Body mass index |
| eGFR | Estimated glomerular filtration rate |
| Hb | Preoperative hemoglobin |
| CKD | Chronic kidney disease |
| EBL | Estimated blood loss |
| LOS | Hospital length of stay |
| AKI | Acute kidney injury |
| ESRD | End-stage renal disease |
| IQR | Interquartile ranges |
| PSM | Positive surgical margin |
| RCC | Renal Cell Carcinoma |
References
- Hinata, N.; Murakami, S.; Nakano, Y.; Hara, I.; Kondo, T.; Hamamoto, S.; Shiroki, R.; Nagayama, J.; Kawakita, M.; Eto, M.; et al. Efficacy of robot-assisted partial nephrectomy compared to conventional laparoscopic partial nephrectomy for completely endophytic renal tumor: A multicenter, prospective study. Int. J. Clin. Oncol. 2024, 29, 1548–1556. [Google Scholar] [CrossRef]
- Mahmud, H.; Erlich, T.; Zilberman, D.E.; Rosenzweig, B.; Portnoy, O.; Dotan, Z.A. Robotic partial nephrectomy is associated with a lower incidence of urine leakage following nephron-sparing surgery for kidney tumors compared to open and laparoscopic approaches. World J. Urol. 2025, 43, 254. [Google Scholar] [CrossRef] [PubMed]
- Peyronnet, B.; Tondut, L.; Bernhard, J.C.; Vaessen, C.; Doumerc, N.; Sebe, P.; Pradere, B.; Guillonneau, B.; Khene, Z.E.; Nouhaud, F.X.; et al. Impact of hospital volume and surgeon volume on robot-assisted partial nephrectomy outcomes: A multicentre study. BJU Int. 2018, 121, 916–922. [Google Scholar] [CrossRef] [PubMed]
- Thakker, P.U.; O’Rourke, T.K., Jr.; Hemal, A.K. Technologic advances in robot-assisted nephron sparing surgery: A narrative review. Transl. Androl. Urol. 2023, 12, 1184–1198. [Google Scholar] [CrossRef] [PubMed]
- Juvet, T.S.; Thompson, R.H.; Potretzke, A.M. Robot-assisted partial nephrectomy is safe and effective for complex renal masses when performed by experienced surgeons. Transl. Androl. Urol. 2020, 9, 2474–2478. [Google Scholar] [CrossRef]
- Deng, W.; Li, J.; Liu, X.; Chen, L.; Liu, W.; Zhou, X.; Zhu, J.; Fu, B.; Wang, G. Robot-assisted versus laparoscopic partial nephrectomy for anatomically complex T1b renal tumors with a RENAL nephrometry score ≥7: A propensity score-based analysis. Cancer Med. 2020, 9, 586–594. [Google Scholar] [CrossRef]
- Brassetti, A.; Misuraca, L.; Anceschi, U.; Bove, A.M.; Costantini, M.; Ferriero, M.C.; Guaglianone, S.; Mastroianni, R.; Torregiani, G.; Covotta, M.; et al. Sutureless Purely off-Clamp Robot-Assisted Partial Nephrectomy: Avoiding Renorrhaphy Does Not Jeopardize Surgical and Functional Outcomes. Cancers 2023, 15, 698. [Google Scholar] [CrossRef]
- Franco, A.; Riolo, S.; Tema, G.; Guidotti, A.; Brassetti, A.; Anceschi, U.; Bove, A.M.; D’Annunzio, S.; Ferriero, M.; Mastroianni, R.; et al. Renal Function Preservation in Purely Off-Clamp Sutureless Robotic Partial Nephrectomy: Initial Experience and Technique. Diagnostics 2024, 14, 1579. [Google Scholar] [CrossRef]
- Anceschi, U.; Ferriero, M.C.; Tuderti, G.; Brassetti, A.; Bertolo, R.; Capitanio, U.; Larcher, A.; Garisto, J.; Antonelli, A.; Mottrie, A.; et al. Head to Head Impact of Margin, Ischemia, Complications, Score Versus a Novel Trifecta Score on Oncologic and Functional Outcomes After Robotic-assisted Partial Nephrectomy: Results of a Multicenter Series. Eur. Urol. Focus. 2021, 7, 1391–1399. [Google Scholar] [CrossRef]
- Pandolfo, S.D.; Wu, Z.; Campi, R.; Bertolo, R.; Amparore, D.; Mari, A.; Verze, P.; Manfredi, C.; Franco, A.; Ditonno, F.; et al. Outcomes and Techniques of Robotic-Assisted Partial Nephrectomy (RAPN) for Renal Hilar Masses: A Comprehensive Systematic Review. Cancers 2024, 16, 693. [Google Scholar] [CrossRef]
- Kutikov, A.; Uzzo, R.G. The RENAL nephrometry score: A comprehensive standardized system for quantitating renal tumor size, location and depth. J. Urol. 2009, 182, 844–853. [Google Scholar] [CrossRef]
- Ficarra, V.; Novara, G.; Secco, S.; Macchi, V.; Porzionato, A.; De Caro, R.; Artibani, W. Preoperative aspects and dimensions used for an anatomical (PADUA) classification of renal tumours in patients who are candidates for nephron-sparing surgery. Eur. Urol. 2009, 56, 786–793. [Google Scholar] [CrossRef] [PubMed]
- Li, X.R.; Li, K.P.; Zuo, J.L.; Yang, W.; Tan, H.; Wang, W.Y.; Chen, S.Y.; Ma, J.H.; Bao, J.S.; Yue, Z.J. Perioperative, functional, and oncologic outcomes of minimally-invasive surgery for highly complex renal tumors (RENAL or PADUA score ≥ 10): An evidence-based analysis. J. Robot. Surg. 2023, 17, 1917–1931. [Google Scholar] [CrossRef] [PubMed]
- Tuderti, G.; Mastroianni, R.; Anceschi, U.; Bove, A.M.; Brassetti, A.; Ferriero, M.; Misuraca, L.; Guaglianone, S.; Costantini, M.; Torregiani, G.; et al. Assessing the Trade-off Between the Safety and Effectiveness of Off-clamp Robotic Partial Nephrectomy for Renal Masses with a High RENAL Score: A Propensity Score-matched Comparison of Perioperative and Functional Outcomes in a Multicenter Analysis. Eur. Urol. Focus. 2023, 9, 1037–1043. [Google Scholar] [CrossRef] [PubMed]
- De Nunzio, C.; Tema, G.; Brassetti, A.; Anceschi, U.; Bove, A.M.; D’Annunzio, S.; Ferriero, M.; Mastroianni, R.; Misuraca, L.; Guaglianone, S.; et al. Purely Off-Clamp Sutureless Robotic Partial Nephrectomy for Novice Robotic Surgeons: A Multi-Institutional Propensity Score-Matched Analysis. J. Clin. Med. 2024, 13, 3553. [Google Scholar] [CrossRef]
- Liu, P.; Li, Y.; Shi, B.; Zhang, Q.; Guo, H. The Outcome of Sutureless in Partial Nephrectomy: A Systematic Review and Meta-Analysis. Biomed. Res. Int. 2022, 2022, 5260131. [Google Scholar] [CrossRef]
- Wu, X.; Zhou, J.; Chen, W.; Cai, W.; Liu, D.; Huang, Y.; Tricard, T.; Chen, Y.; Xue, W. Retroperitoneoscopic Clampless, Sutureless Hybrid Therapy in the Management of Renal Hilar Tumors. Ann. Surg. Oncol. 2024, 31, 681–687. [Google Scholar] [CrossRef]
- Rac, G.; Ellis, J.L.; Lanzotti, N.J.; McCormick, M.E.; Felice, M.D.; Janakiraman, S.; Desai, S.; Halgrimson, W.; Patel, H.D.; Gupta, G.N. The evolution of tumor enucleation partial nephrectomy: A comparison of perioperative outcomes for sutureless hemostatic bandage as an alternative to standard renorrhaphy. J. Surg. Oncol. 2024, 130, 653–658. [Google Scholar] [CrossRef]
- Schiavina, R.; Bianchi, L.; Borghesi, M.; Chessa, F.; Cercenelli, L.; Marcelli, E.; Brunocilla, E. Three-dimensional digital reconstruction of renal model to guide preoperative planning of robot-assisted partial nephrectomy. Int. J. Urol. 2019, 26, 931–932. [Google Scholar] [CrossRef]
- Giulioni, C.; Di Biase, M.; Marconi, A.; Sortino, G.; Diambrini, M.; Iacovelli, V.; Giannubilo, W.; Ferrara, V. Clampless Laparoscopic Tumor Enucleation for Exophytic Masses Greater Than 4 cm: Is Renorrhaphy Necessary? J. Laparoendosc. Adv. Surg. Tech. A 2022, 32, 931–937. [Google Scholar] [CrossRef]
- Ito, H.; Nakane, K.; Hagiwara, N.; Kawase, M.; Kato, D.; Iinuma, K.; Ishida, K.; Enomoto, T.; Nezasa, M.; Tobisawa, Y.; et al. Impact of Robotic-Assisted Partial Nephrectomy with Single Layer versus Double Layer Renorrhaphy on Postoperative Renal Function. Curr. Oncol. 2024, 31, 2758–2768. [Google Scholar] [CrossRef]
- Li, W.; Hua, B.; Song, S.; Pan, W.; Yang, Q.; Xu, B. From sutureless to standard: A comprehensive analysis of conversion rates in laparoscopic partial nephrectomy. BMC Urol. 2024, 24, 183. [Google Scholar] [CrossRef]
- Shatagopam, K.; Bahler, C.D.; Sundaram, C.P. Renorrhaphy techniques and effect on renal function with robotic partial nephrectomy. World J. Urol. 2020, 38, 1109–1112. [Google Scholar] [CrossRef]
- Kilic, S.; Ates, M. Sutureless versus conventional suture renorrhaphy in clampless robotic partial nephrectomy: A single center propensity score matching analysis. Actas Urol. Esp. 2025, 49, 501704. [Google Scholar] [CrossRef]
- Tufano, A.; Asero, V.; Proietti, F.; Flammia, R.S.; Franco, G.; Leonardo, C. Arteriovenous fistula after robotic partial nephrectomy: Case report and narrative review. Radiol. Case Rep. 2022, 17, 2550–2553. [Google Scholar] [CrossRef] [PubMed]
- Anceschi, U.; Brassetti, A.; Tuderti, G.; Consiglia Ferriero, M.; Minervini, A.; Mari, A.; Grosso, A.A.; Carini, M.; Capitanio, U.; Larcher, A.; et al. Risk factors for progression of chronic kidney disease after robotic partial nephrectomy in elderly patients: Results from a multi-institutional collaborative series. Minerva Urol. Nephrol. 2022, 74, 452–460. [Google Scholar] [CrossRef] [PubMed]
- Sharma, G.; Shah, M.; Ahluwalia, P.; Dasgupta, P.; Challacombe, B.J.; Bhandari, M.; Ahlawat, R.; Rawal, S.; Buffi, N.M.; Sivaraman, A.; et al. Development and Validation of a Nomogram Predicting Intraoperative Adverse Events During Robot-assisted Partial Nephrectomy. Eur. Urol. Focus. 2023, 9, 345–351. [Google Scholar] [CrossRef] [PubMed]
- Subirá-Rios, D.; Trapero-Moreno, D.; Caño-Velasco, J.; González-García, J.; Moncada-Iribarren, I.; Aragón-Chamizo, J.; Fernández-Tamayo, A.; DEMiguel-Campos, E.; Subirá-Ríos, J.; Perez-Mañanes, R.; et al. A new surgical technique for sutureless partial nephrectomy: Renal sutureless device. Minerva Urol. Nephrol. 2023, 75, 521–528. [Google Scholar] [CrossRef]
- Amparore, D.; Sica, M.; Verri, P.; Piramide, F.; Checcucci, E.; De Cillis, S.; Piana, A.; Campobasso, D.; Burgio, M.; Cisero, E.; et al. Computer Vision and Machine-Learning Techniques for Automatic 3D Virtual Images Overlapping During Augmented Reality Guided Robotic Partial Nephrectomy. Technol. Cancer Res. Treat. 2024, 23, 15330338241229368. [Google Scholar] [CrossRef]
- Hua, J.; Chen, X. Accuracy of RENAL nephrometry score in predicting perioperative outcomes of minimally invasive partial nephrectomy: Impact of different surgical techniques. Transl. Androl. Urol. 2025, 14, 124–134. [Google Scholar] [CrossRef]

| Variable (n, %) | Sutureless n = 101 (50.2%) | Renorrhaphy n = 100 (49.8%) | p-Value |
|---|---|---|---|
| Age (years, median [IQR]) | 64 [58–70] | 65 [59–71] | 0.65 |
| BMI (kg/m2, median [IQR]) | 26.4 [24.2–29.3] | 26.9 [24.8–30.1] | 0.48 |
| ASA score (n, %) 1–2 3–4 | 60 (59.4%) 41 (40.6%) | 54 (54%) 46 (46%) | 0.59 |
| Gender (n,%) Male Female | 62 (61.4%) 39 (38.6%) | 64 (64%) 36 (36%) | 0.72 |
| Diabetes (n,%) | 18 (17.8%) | 20 (20%) | 0.71 |
| Hypertension (n,%) | 57 (56.4%) | 62 (62%) | 0.42 |
| Surgical approach (n,%) Laparoscopic Robotic | 12 (11.9%) 89 (88.1%) | 13 (13%) 87 (87%) | 0.84 |
| Tumor side (n, %) Right Left | 52 (51.5%) 49 (48.5%) | 50 (50%) 50 (50%) | 0.66 |
| Clinical tumor size (cm, median [IQR]) | 3.1 [2.4–4.3] | 3.6 [2.6–4.8] | 0.04 |
| Preoperative eGFR (mL/min/1.73 m2, median [IQR]) | 82 [72–91] | 78 [68–88] | 0.06 |
| Preoperative hemoglobin (g/dL, median [IQR]) | 13.8 [12.9–14.7] | 13.6 [12.8–14.5] | 0.21 |
| R.E.N.A.L. score (median [IQR]) | 7 [6–9] | 7 [6–9] | 0.88 |
| R.E.N.A.L. score (n, %) 4–6 (low complexity) 7–9 (moderate complexity) 10–12 (high complexity) | 25 (24.8%) 66 (65.3%) 10 (9.9%) | 24 (24%) 66 (66%) 10 (10%) | 0.94 |
| Clinical T stage (n, %) cT1a cT1b cT2 | 62 (61.4%) 35 (34.7%) 4 (4%) | 59 (59%) 36 (36%) 5 (5%) | 0.73 |
| Preoperative CKD stage (n,%) 1 2 3a | 42 (41.6%) 50 (49.5%) 9 (8.9%) | 39 (39%) 52 (52%) 9 (9%) | 0.95 |
| Variable (n, %) | Sutureless n = 101 (50.2%) | Renorrhaphy n = 100 (49.8%) | p-Value |
|---|---|---|---|
| Operative time | 65 (55–80) | 65 (50–80) | 0.80 |
| Estimated blood loss (mL, median, IQR) | 100 (60–180) | 105 (60–190) | 0.69 |
| Hb at discharge (g/dL, median, IQR) | 11.9 (10.9–12.8) | 11.7 (10.7–12.7) | 0.42 |
| ΔHb (g/dL, median, IQR) | −2.1 (−1.1; −3.1) | −2.2 (−1.2; −3.2) | 0.61 |
| Perioperative complications (Clavien–Dindo, n, %) Clavien I-II Grade ≥ 3 | 5 (5.0%) fever (n = 2), transient ileus (n = 1), transfusion (n = 2) 1 (1.0%) urinoma requiring percutaneous drainage | 9 (9.0%) transfusion (n = 4), fever (n = 2), anemia requiring iron (n = 3) 1 (1.0%)urinary leakage requiring double-J stenting | 0.45 |
| PSM (n, %) | 1 (1.0%) | 2 (2.0%) | 0.38 |
| LOS (days, median, IQR) | 4 (3–5) | 4 (3–5) | 0.83 |
| eGFR at discharge (mL/min/1.73 m2, median, IQR) | 52.3 (43.1–63.7) | 51.5 (42.0–62.2) | 0.71 |
| ΔeGFR (median, IQR) | −9.3 (IQR −5.1 to −22.4; 95% CI −11.2 to −7.4) | −9.7 (IQR −5.4 to −23.1; 95% CI −11.6 to −7.8) | 0.74 |
| AKI (ΔeGFR >50%, n, %) | 1 (1.0%) | 4 (4.0%) | 0.18 |
| pT stage (n, %) pT1a pT1b pT2-pT3a | 65 (64.4%) 23 (22.8%) 13 (12.9%) | 60 (60%) 25 (25%) 15 (15%) | 0.11 |
| Histology (n,%) Benign RCC or other malignant | 18 (17.8%) 83 (82.2%) | 14 (14%) 86 (86%) | 0.26 |
| Variable | Overall Cohort (n = 201) | Renorrhaphy (n = 100) | Sutureless (n = 101) | p-Value |
|---|---|---|---|---|
| Follow-up (months, median, IQR) | 26 (18–34) | 25 (18–33) | 27 (19–35) | 0.48 |
| eGFR at last follow-up (mL/min/1.73 m2) | 58.1 (47.6–69.4) | 56.3 (45.8–67.9) | 60.2 (49.2–70.8) | 0.21 |
| CKD stage at last follow-up (n, %) 1 2 3a 3b 4 5 | 28 (13.9%) 49 (24.4%) 105 (52.2%) 15 (7.5%) 3 (1.5%) 1 (0.5%) | 12 (12%) 22 (22%) 53 (53%) 9 (9%) 3 (3%) 1 (1%) | 16 (15.8%) 27 (26.7%) 52 (51.5%) 6 (5.9%) - - | 0.43 |
| Severe CKD upstaging (≥stage 3b), n (%) | 7 (3.5%) | 5 (5.0%) | 2 (2.0%) | 0.28 |
| Newly onset ESRD (n, %) | 1 (0.5%) | 1 (1.0%) | 0 (0.0%) | 0.32 |
| Trifecta achievement (n, %) | 182 (90.5%) | 89 (89.0%) | 93 (92.1%) | 0.41 |
| Variable | Univariable Analysis | Multivariable Analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95.0% CI | OR | 95.0% CI | |||||
| Lower | Higher | p-Value | Lower | Higher | p-Value | |||
| Gerota thickness (<10 mm vs. >10 mm) | 0.24 | 0.08 | 0.69 | 0.008 | 0.39 | 0.10 | 1.39 | 0.14 |
| Contact surface area (>15 cm2 vs. <15 cm2) | 4.77 | 2.47 | 9.21 | <0.001 | 5.48 | 2.38 | 12.6 | <0.001 |
| R.E.N.A.L. score (4–6 vs. 7–9 4–6 vs. 10–12) | 0.79 2.16 | 0.40 0.95 | 1.54 4.89 | 0.49 0.06 | - - | - - | - - | - - |
| Renal antero-posterior diameter (mm) | 1.01 | 0.98 | 1.04 | 0.266 | - | - | - | - |
| Renal latero-lateral diameter (mm) | 1.03 | 0.99 | 1.06 | 0.07 | - | - | - | - |
| Renal length superior-inferior diameter (mm) | 1.02 | 0.99 | 1.04 | 0.08 | - | - | - | - |
| Medullary invasion (no vs. yes) | 2.02 | 0.63 | 6.43 | 0.233 | - | - | - | - |
| Margin (linear vs. irregular) | 1.20 | 0.57 | 2.52 | 0.616 | - | - | - | - |
| Tumor pseudocapsule (no vs. yes) | 1.40 | 0.71 | 2.77 | 0.325 | - | - | - | - |
| Necrosis (no vs. yes) | 1.36 | 0.68 | 2.73 | 0.378 | - | - | - | - |
| Nature of the tumour (cystic vs. solid) | 1.87 | 0.92 | 3.80 | 0.08 | - | - | - | - |
| Variable | Univariable Analysis | Multivariable Analysis | ||||||
|---|---|---|---|---|---|---|---|---|
| OR | 95.0% CI | OR | 95.0% CI | |||||
| Lower | Higher | p-Value | Lower | Higher | p-Value | |||
| Gerota thickness (<10 mm vs. >10 mm) | 0.24 | 0.08 | 0.69 | 0.008 | 0.08 | 0.01 | 0.70 | 0.02 |
| Distance from mass to renal sinus (mm) | 0.94 | 0.90 | 0.99 | 0.032 | 1.02 | 0.92 | 1.14 | 0.66 |
| Contact surface area (>15 cm2 vs. <15 cm2) | 4.77 | 2.47 | 9.21 | <0.001 | 3.93 | 1.26 | 12.26 | 0.02 |
| Tumor depth (mm) | 1.06 | 1.03 | 1.09 | <0.001 | 1.04 | 0.96 | 1.12 | 0.36 |
| Tumor radius (mm) | 1.05 | 1.01 | 1.08 | 0.002 | 1.14 | 1.01 | 1.29 | 0.04 |
| Nearness to collecting system (mm) | 0.86 | 0.78 | 0.94 | 0.001 | 0.92 | 0.78 | 1.08 | 0.30 |
| Antero-posterior diameter renal mass (mm) | 1.02 | 1.008 | 1.043 | 0.003 | 0.99 | 0.92 | 1.08 | 0.93 |
| Latero-lateral diameter renal mass (mm) | 1.02 | 1.008 | 1.043 | 0.004 | 1.03 | 0.94 | 1.13 | 0.54 |
| R.E.N.A.L. score (4–6 vs. 7–9 4–6 vs. 10–12) | 0.79 2.16 | 0.40 0.95 | 1.54 4.89 | 0.49 0.064 | - - | - - | - - | - - |
| Renal antero-posterior diameter (mm) | 1.01 | 0.98 | 1.04 | 0.266 | - | - | - | - |
| Renal latero-lateral diameter (mm) | 1.03 | 0.99 | 1.06 | 0.07 | - | - | - | - |
| Renal length superior-inferior diameter (mm) | 1.02 | 0.99 | 1.04 | 0.08 | - | - | - | - |
| Medullary invasion (no vs. yes) | 2.02 | 0.63 | 6.43 | 0.233 | - | - | - | - |
| Hilar mass (no vs. yes) | 1.56 | 0.65 | 3.75 | 0.313 | - | - | - | - |
| Margin (linear vs. Irregular) | 1.20 | 0.57 | 2.52 | 0.616 | - | - | - | - |
| Tumor pseudocapsule (no vs. yes) | 1.40 | 0.71 | 2.77 | 0.325 | - | - | - | - |
| Necrosis (no vs. yes) | 1.36 | 0.68 | 2.73 | 0.378 | - | - | - | - |
| Nature of the tumour (cystic vs. solid) | 1.87 | 0.92 | 3.80 | 0.08 | - | - | - | - |
| Renal rim (medial vs. lateral) | 0.72 | 0.38 | 1.35 | 0.307 | - | - | - | - |
| Location relative to polar line Upper vs. middle Upper vs. lower | 2.08 1.37 | 0.95 0.70 | 4.54 2.65 | 0.06 0.35 | - - | - - | - - | - - |
| Tumor location (anterior vs. posterior) | 0.72 | 0.40 | 1.32 | 0.301 | - | - | - | - |
| Longitudinal location Upper vs. middle Upper vs. lower | 0.60 0.60 | 0.29 0.29 | 1.24 1.25 | 0.17 0.17 | - - | - - | - - | - - |
| Exopythic rate >50 vs. < 50% >50% vs. endophytic | 1.18 1.65 | 0.64 0.51 | 2.17 5.30 | 0.59 0.39 | - - | - - | - - | - - |
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Anceschi, U.; Tufano, A.; Vitale, D.; Prata, F.; Flammia, R.S.; Cappelli, F.; Teodoli, L.; Trobiani, C.; Vallati, G.E.; Minore, A.; et al. Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy. Cancers 2025, 17, 3236. https://doi.org/10.3390/cancers17193236
Anceschi U, Tufano A, Vitale D, Prata F, Flammia RS, Cappelli F, Teodoli L, Trobiani C, Vallati GE, Minore A, et al. Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy. Cancers. 2025; 17(19):3236. https://doi.org/10.3390/cancers17193236
Chicago/Turabian StyleAnceschi, Umberto, Antonio Tufano, Davide Vitale, Francesco Prata, Rocco Simone Flammia, Federico Cappelli, Leonardo Teodoli, Claudio Trobiani, Giulio Eugenio Vallati, Antonio Minore, and et al. 2025. "Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy" Cancers 17, no. 19: 3236. https://doi.org/10.3390/cancers17193236
APA StyleAnceschi, U., Tufano, A., Vitale, D., Prata, F., Flammia, R. S., Cappelli, F., Teodoli, L., Trobiani, C., Vallati, G. E., Minore, A., Basile, S., Mastroianni, R., Brassetti, A., Tuderti, G., Iori, M., Spadaro, G., Ferriero, M., Bove, A. M., Vergantino, E., ... Simone, G. (2025). Profiling the Kidney Before the Incision: CT-Derived Signatures Steering Reconstructive Strategy After Off-Clamp Minimally Invasive Partial Nephrectomy. Cancers, 17(19), 3236. https://doi.org/10.3390/cancers17193236

